Healthcare Finance Staff

The federal government has granted itself potent new authority to expel physicians from Medicare if they are found to prescribe drugs in abusive ways, following through on a proposal issued earlier this year.

AmeriMark Direct started its mail order catalog business here in the 1960s, and for decades, everyone assumed that health insurance came with the job.

With millions of Americans on new exchange plans now responsible for high deductibles, hospitals, drug makers, insurers and regulators are entering a new frontier of payment disputes.

As more exchange enrollment data emerges, so too is a premium strategy that in the long-run may act as a market check of sorts.

Highmark is changing its CEO for the third time in as many years. An executive whose work spans jewelry, fabrics and eyeglasses is taking the helm of a new integrated payer-provider in the early stages of a market war.

The breakthrough hepatitis drug Sovaldi has sparked a vigorous debate about the financial sustainability of U.S. healthcare and the role of government in regulating prices.

A challenge to a Blue Cross company's recoupment practices has ended in victory for a group of chiropractors and with a favorable precedent for providers who want to appeal the decisions of certain health plans.

In an era of increasing consolidation, some insurers are taking a slightly different route on the health reform journey.

Consumer concerns about new health plan networks continue, with two new members suing over a preferred provider network they say was deceitfully marketed.

As a payer and provider and the country's largest managed care organization with a lot of digital and online patient data, Kaiser Permanente has tried to address privacy and security head-on, and may pave a way for others.